Ligand validation:8AKA

STL: RESVERATROL

STL is a Ligand Of Interest in 8AKA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AKA_STL_B_404	57%	36%	0.14	0.914	1.55	1	3	1	1	0	100%	1
8AKA_STL_A_403	56%	26%	0.142	0.914	1.84	1.15	6	1	1	0	100%	1
8CNO_STL_A_403	87%	30%	0.091	0.964	1.54	1.27	3	2	0	0	100%	1
5U90_STL_D_602	95%	61%	0.064	0.968	0.8	0.69	-	-	0	0	100%	1
7VB8_STL_B_401	94%	74%	0.075	0.976	0.42	0.59	-	-	0	0	100%	1
7Q9O_STL_A_201	92%	55%	0.08	0.972	1.1	0.66	2	-	2	0	100%	0.5
8W42_STL_A_200	84%	42%	0.089	0.952	1.39	0.87	3	2	0	0	100%	0.5
4QOJ_STL_B_302	83%	81%	0.097	0.957	0.2	0.61	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.